Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.

Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, Ferguson NM, Garske T, Mills HL, Riley S, Van Kerkhove MD, Hernán MA.

PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003846. doi: 10.1371/journal.pntd.0003846. eCollection 2015. Review.

2.

Infectious disease modeling methods as tools for informing response to novel influenza viruses of unknown pandemic potential.

Gambhir M, Bozio C, O'Hagan JJ, Uzicanin A, Johnson LE, Biggerstaff M, Swerdlow DL.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S11-9. doi: 10.1093/cid/civ083. Review.

3.
4.

Outbreak of Influenza (H1N1) amongst children in a residential school.

Kushwaha AS, Teli P, Mahen A.

Med J Armed Forces India. 2014 Jul;70(3):274-6. doi: 10.1016/j.mjafi.2013.01.008. Epub 2013 Jun 6.

5.

Transmission characteristics of different students during a school outbreak of (H1N1) pdm09 influenza in China, 2009.

Wang L, Chu C, Yang G, Hao R, Li Z, Cao Z, Qiu S, Li P, Wu Z, Yuan Z, Xu Y, Zeng D, Wang Y, Song H.

Sci Rep. 2014 Aug 7;4:5982. doi: 10.1038/srep05982.

6.

Evaluation of the spread of pandemic influenza A/H1N1 2009 among Japanese university students.

Uchida M, Kaneko M, Tsukahara T, Washizuka S, Kawa S.

Environ Health Prev Med. 2014 Sep;19(5):315-21. doi: 10.1007/s12199-014-0396-4. Epub 2014 Jul 4. Review.

7.

Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk.

Skowronski DM, Hamelin ME, De Serres G, Janjua NZ, Li G, Sabaiduc S, Bouhy X, Couture C, Leung A, Kobasa D, Embury-Hyatt C, de Bruin E, Balshaw R, Lavigne S, Petric M, Koopmans M, Boivin G.

PLoS One. 2014 Jan 27;9(1):e86555. doi: 10.1371/journal.pone.0086555. eCollection 2014.

8.

Use of a web forum and an online questionnaire in the detection and investigation of an outbreak.

Stuart Chester TL, Taylor M, Sandhu J, Forsting S, Ellis A, Stirling R, Galanis E.

Online J Public Health Inform. 2011;3(1). pii: ojphi.v3i1.3506. doi: 10.5210/ojphi.v3i1.3506. Epub 2011 Jun 22.

9.

The epidemiology and surveillance response to pandemic influenza A (H1N1) among local health departments in the San Francisco Bay Area.

Enanoria WT, Crawley AW, Tseng W, Furnish J, Balido J, Aragón TJ.

BMC Public Health. 2013 Mar 27;13:276. doi: 10.1186/1471-2458-13-276.

10.

Reasons for Low Pandemic H1N1 2009 Vaccine Acceptance within a College Sample.

Ravert RD, Fu LY, Zimet GD.

Adv Prev Med. 2012;2012:242518. doi: 10.1155/2012/242518. Epub 2012 Nov 28.

11.

Characterization of immune responses induced by immunization with the HA DNA vaccines of two antigenically distinctive H5N1 HPAIV isolates.

Gao Y, Wen Z, Dong K, Zhong G, Wang X, Bu Z, Chen H, Ye L, Yang C.

PLoS One. 2012;7(7):e41332. doi: 10.1371/journal.pone.0041332. Epub 2012 Jul 31.

12.

Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.

Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Miller MA, Fernández-Gárate I, González-Bonilla C, Borja-Aburto VH.

PLoS One. 2012;7(7):e41069. doi: 10.1371/journal.pone.0041069. Epub 2012 Jul 16.

13.

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O.

BMC Infect Dis. 2012 May 31;12:127. doi: 10.1186/1471-2334-12-127.

14.
15.

No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.

Mahmud SM, Van Caeseele P, Hammond G, Kurbis C, Hilderman T, Elliott L.

Emerg Infect Dis. 2012 May;18(5):801-10. doi: 10.3201/eid1805.111596.

16.

Two years after pandemic influenza A/2009/H1N1: what have we learned?

Cheng VC, To KK, Tse H, Hung IF, Yuen KY.

Clin Microbiol Rev. 2012 Apr;25(2):223-63. doi: 10.1128/CMR.05012-11. Review.

17.

Perceptions of pandemic influenza vaccines.

Marczinski CA.

Hum Vaccin Immunother. 2012 Feb;8(2):275-8. doi: 10.4161/hv.18457. Epub 2012 Feb 1. No abstract available.

18.

College students' perceptions of H1N1 flu risk and attitudes toward vaccination.

Ramsey MA, Marczinski CA.

Vaccine. 2011 Oct 13;29(44):7599-601. doi: 10.1016/j.vaccine.2011.07.130. Epub 2011 Aug 7.

19.

Risk factors for pandemic (H1N1) 2009 seroconversion among adults, Singapore, 2009.

Lim WY, Chen CH, Ma Y, Chen MI, Lee VJ, Cook AR, Tan LW, Flores Tabo N Jr, Barr I, Cui L, Lin RT, Leo YS, Chia KS.

Emerg Infect Dis. 2011 Aug;17(8):1455-62. doi: 10.3201/eid1708.101270.

20.

Epidemiology of influenza-like illness during Pandemic (H1N1) 2009, New South Wales, Australia.

Muscatello DJ, Barr M, Thackway SV, Macintyre CR.

Emerg Infect Dis. 2011 Jul;17(7):1240-7. doi: 10.3201/eid1707.101173.

Supplemental Content

Support Center